Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020-Reference-Cited by-同舟云学术

Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020

Published:2020-01-01 Issue: Volume:26 Page:107602962093635
ISSN:1076-0296
Container-title:Clinical and Applied Thrombosis/Hemostasis
language:en
Short-container-title:Clin Appl Thromb Hemost

Author:

Ramacciotti Eduardo¹²³^ORCID,Macedo Ariane Scarlatelli²^ORCID,Biagioni Rodrigo Bruno⁴,Caffaro Roberto Augusto²,Lopes Renato Delascio⁵,Guerra João Carlos⁶⁷,Orsi Fernanda Andrade⁸^ORCID,Marques Marcos Areas⁹,Tafur Alfonso J.¹⁰,Caprini Joseph A.¹⁰,Nicolaides Andrew¹¹,Carter Charles A.¹²^ORCID,Filho Cyrillo Carvalheiro¹³¹⁴^ORCID,Fareed Jawed³^ORCID

Affiliation:

1. Hospital Christóvão da Gama, Grupo Leforte, Santo André, São Paulo, Brazil

2. Santa Casa de Sao Paulo School of Medical Sciences, São Paulo, São Paulo, Brazil

3. Hemostasis & Thrombosis Research Laboratories at Loyola University Medical Center, Maywood, IL, USA

4. São Paulo State Public Servant Hospital, São Paulo, Brazil

5. Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA

6. Hospital Israelita Albert Einstein, São Paulo, Brazil

7. Centro de Hematologia de São Paulo, São Paulo, Brazil

8. School of Medical Sciences University of Campinas, São Paulo, Brazil

9. School of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

10. NorthShore University Health System, Skokie, IL, USA

11. Vascular Screening and Diagnostic Centre and University of Nicosia Medical School, Nicosia, Cyprus

12. Department of Clinical Research, College of Pharmacy & Health Sciences, Campbell University, NC, USA

13. Hospital Sirio-Libanês, São Paulo, Brazil

14. Heart Institute, University of São Paulo, São Paulo, Brazil

Abstract

This practical guidance, endorsed by the Brazilian Society of Thrombosis and Hemostasis and The Brazilian Society of Angiology and Vascular Surgery, the International Union of Angiology and the European Venous Forum, aims to provide physicians with clear guidance, based on current best evidence-based data, on clinical strategies to manage antithrombotic strategies in patients with coronavirus disease 2019.

Publisher

SAGE Publications

Subject

Hematology,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/1076029620936350

Reference25 articles.

1. COVID-19 and Cardiovascular Disease

2. Thrombosis as an intravascular effector of innate immunity

3. Current Perspectives on Coronavirus Disease 2019 and Cardiovascular Disease: A White Paper by the JAHA Editors

4. Zika and Chikungunya Virus and Risk for Venous Thromboembolism

5. Evaluation of Soluble P-Selectin as a Marker for the Diagnosis of Deep Venous Thrombosis

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombotic complications in children and adolescents with SARS-CoV-2 infection;International and Life Course Aspects of COVID-19;2024

2. Prophylactic anticoagulants for non-hospitalised people with COVID-19;Cochrane Database of Systematic Reviews;2023-08-16

3. COVID-19-associated Coagulopathy Characterization using Rotational Thromboelastometry in a Prospective, Observational Cohort Study: The HemoCoV Study;Acta Médica Portuguesa;2023-07-03

4. Anticoagulants for people hospitalised with COVID-19;Cochrane Database of Systematic Reviews;2022-03-04

5. SARS‐CoV‐2‐related and Covid‐19 vaccine‐induced thromboembolic events: A comparative review;Reviews in Medical Virology;2022-02-03